Marvell Technology and Bausch Health purchased
Bausch Health: “We wanted to buy more today but time ran out. This thing is on sale. There are shorts for full price. That’s ridiculous. I want to be able to buy a giant slug. that’s it. today, so that’s how I feel [Charitable Trust]. “
Voice mark: “They crushed that stock. The business was great. They had a great quarter. I’m telling everyone. [buy, buy, buy]. “
Cellularity: “It’s one of the riskier stocks out there. The way I look at it is, prepare to lose it all but otherwise make a lot of money.”
Manulife: “They take too much risk, Manulife. I’m not there for the 5% [dividend yield]. I do not need it. Too much risk in common stock. “
Marvell Technology: “You should [keep buying more of it]. The company has two businesses: high-performance computing and 5G. We know those are the two strongest areas. It has no PC business. It has no games. Marvell is the stock we bought, bought, bought for the Charity, and I think you should too. “
Iron Mountain: “I like Iron Mountain. Good productivity, very stable business. [Buy, buy, buy]. “
Disclosure: Cramer’s Charity Trust owns shares of BHC and MRVL.
Register now for CNBC Investment Club to track Jim Cramer’s every move in the markets.